Filing Details

Accession Number:
0000896264-24-000224
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-05 12:57:04
Reporting Period:
2024-11-02
Accepted Time:
2024-11-05 12:57:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203302 A Gilbert Fuller 3838 West Parkway Blvd
Salt Lake City UT 84120
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-02 675 $0.00 675 No 4 M Direct
Common Stock Disposition 2024-11-04 675 $37.71 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2024-11-02 675 $0.00 675 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,348 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  2. Restricted Stock Units vest 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.